IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Phaxiam Therapeutics S A

CUSIP: 29604W207 | 4 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Asset Dedication, LLC400
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Asset Dedication, LLC
400$10.0%ETFLowSan Francisco, CA2024-04-16